4//SEC Filing
Goldan Keith A. 4
Accession 0000950170-25-105258
CIK 0001395937other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 5:30 PM ET
Size
4.7 KB
Accession
0000950170-25-105258
Insider Transaction Report
Form 4
Goldan Keith A.
Chief Financial Officer
Transactions
- Other
Common Stock
2025-07-31$8.43/sh+1,226$10,335→ 93,676 total
Footnotes (1)
- [F1]The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,226 shares by the Reporting Person on 07/31/2025 pursuant to the Issuer's Employee Stock Purchase Plan.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001495411
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 5:30 PM ET
- Size
- 4.7 KB